Irritable Bowel Syndrome Treatment Market Industry Will Grow Steadily with Leading Players Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc.,
Manufacturers are focusing on upgrading the available treatment options as well as developing new solutions for symptom specific irritable bowel syndrome. Allergan plc received the U.S. Food & Drug Administration (FDA) approval for Viberzi (eluxadoline) for the treatment of IBS in adult men and women in 2015. Also, the company received approval of Health Canada for IBS-D in 2017. Valeant Pharmaceuticals International, Inc. received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan for the treatment of IBS-D in 2015.
Download PDF Brochure of This Business Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/506
The major players are also expanding the product portfolio and their IBS therapies through mergers and acquisitions. Valeant Pharmaceuticals International, Inc. acquired Salix Pharmaceuticals, Inc. in 2015 along with the latter’s popular brand Xifaxan. The manufacturers are spreading the awareness about IBS through direct-to-consumer campaign advertisements for IBS drugs. For instance, Allergan and Ironwood Pharmaceuticals launched the first DTC campaign for Viberzi in 2015.
Furthermore, Sucampo Pharmaceuticals, Inc.’s pipeline products include lubiprostone for pediatric functional constipation (6 years – 17 years) in phase two and lubiprostone alternate formulation for pediatric constipation (6 months – 6 years). Also, Ardelyx, Inc. reported successful phase 3 T3MPO trial of Tenapanor in patients with irritable bowel syndrome with constipation.
Astellas Pharma, Inc. is conducting clinical trials for ASP7147, in the treatment of IBS. Norgine B.V. is having Plenvu, as osmotic laxative in clinical trials and the company entered into an agreement with Noventure to commercialize Gelsectan in Spain, Portugal and Andorra in 2017. Synthetic Biologics, Inc. is developing SYN-010 (modified-release reformulation of lovastatin lactone) as a therapy in irritable bowel syndrome with constipation.
Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market.
Request For Customization Of This Business Research Report:
Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel:
Global Irritable Bowel Syndrome Treatment Market, By Geography:
By Drug Type:
By Medical Condition:
By Distribution Channel:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,, #3200, Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Irritable Bowel Syndrome Treatment Market Industry Will Grow Steadily with Leading Players Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., here
News-ID: 1457255 • Views: 3698
More Releases from Coherent Market Insights
Adsorption Equipment Market Size, Share, Trend, COVID-19 Impact and Growth Analy …
Summary of the Report - CMI's latest report, global "Adsorption Equipment Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - CECO Environmental, Dürr AG, Evoqua Water Technologies LLC, TIGG LLC, Chemisch Thermal Prozesstechnik GmbH (CTP), Taikisha Ltd., ENVIRONMENTAL C & C INC, Gulf Coast Environmental Systems. ▪ Profiles of 5 leading companies
Battery Alloys Market Trends and Opportunities Report by Forecast to 2028 | Cohe …
Summary of the Report - CMI's latest report, global "Battery Alloys Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Furukawa Co. Ltd, Mitsubishi Corporation. ▪ Profiles of 5 leading companies in the industry - overview, key strategies, financials, and products ▪ Latest market news and developments Detailed Competitive Landscape - The Competitive Landscape of
South Africa Automotive Trailer Wheel Rims Market Growth Drivers 2022, Industry …
𝗧𝗵𝗲 𝗴𝗹𝗼𝗯𝗮𝗹 𝗦𝗼𝘂𝘁𝗵 𝗔𝗳𝗿𝗶𝗰𝗮 𝗔𝘂𝘁𝗼𝗺𝗼𝘁𝗶𝘃𝗲 𝗧𝗿𝗮𝗶𝗹𝗲𝗿 𝗪𝗵𝗲𝗲𝗹 𝗥𝗶𝗺𝘀 𝗺𝗮𝗿𝗸𝗲𝘁 𝗶𝘀 𝗲𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝗱 𝘁𝗼 𝗮𝗰𝗰𝗼𝘂𝗻𝘁 𝗳𝗼𝗿 𝗨𝗦$ 𝟯𝟮𝟰 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗯𝘆 𝟮𝟬𝟮𝟲 Summary of the Report - CMI's latest report, global "South Africa Automotive Trailer Wheel Rims Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and the supply-demand environment of top companies - Arconic, BORBET GmbH, Burquip, Enkei, Globalwheels, JBH Wheels, MAXION
Accounting Practice Management Market Trend Study 2022-2027 Global Overview by I …
The global accounting practice management market was valued at US$ 2,693.9 million in 2018 and is expected to increase to US$ 6,455.1 million by 2027, registering a CAGR of 13.7% over the forecast period from 2019 to 2027. Summary of the Report - CMI's latest report, global "Accounting Practice Management Market" Research 2022, provides a qualitative analysis of the top emerging regions, including development trends, CAGR value, expected growth, constraints, and
More Releases for IBS
Admissions Open for the PGDM program at SRMS IBS, Lucknow
Shri Ram Murti Smarak (SRMS) International Business School (IBS), Lucknow is currently accepting applications for its full-time, 2-year Post-Graduate Diploma in Management (PGDM). SRMS IBS offers its AICTE approved PGDM with specialisations offered in Banking, Marketing, Finance, International Business, Human Resource Management & Information Technology The B-school is part of the renowned SRMS Trust, which has continuously worked towards providing value-based education to its students across Medical, Engineering, and Management studies since
Cathay Pacific selects IBS Solution to help manage staff travel
Cathay Pacific has signed a multi-million dollar contract to implement IBS’ new generation solution, iFly Staff, to automate and improve the management of employee travel. iFly Staff will also be used for Cathay Pacific subsidiaries including sister airline Dragonair. The implementation of iFly Staff will result in an automated staff travel solution that supports the eligibility and entitlements offered to the airline’s employees and their dependants.
HaCon and IBS combine expertise in railway operation
Hanover (2010-07-06). Two Hanoverian companies now combine their expertise in questions of railway operations: With effect from 1 July 2010, the HaCon Ingenieurgesellschaft mbH, took over the engineering firm for railway operating systems (Ingenieurbüro für Bahnbetriebssysteme GmbH – IBS). This way HaCon expanded its services to include the areas operation simulation, vehicle and personnel planning and construction operations planning. This also includes consulting services concerning railway systems issues, such as travel
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011. The new bulkers, each with a capacity of 176,000 dwt, will be equipped
CoCoNet enhances MULTIVERSA IBS by OFTP access protocol
CoCoNet enhances the modern e-banking-platform MULTIVERSA IBS International Banking Server through an OFTP access channel (Odette File Transfer Protocol) for the data transmission between international banks and corporate customers. MULTIVERSA IBS is a modular and scalable platform for receiving and processing payment transaction data and delivering customer specific account information like account statements, intraday reports, returns and foreign exchange rate information. The initial situation at banks that now also offer
Maldivian uses IBS’ Passenger Services System
Trivandrum, 22 Sep 2008 – Maldivian, the national airline of Maldives, has gone live with IBS’ new-generation Passenger Service System, aiRES in the Software as a Service (SaaS) mode. The solution will help the airline manage its passenger reservations, inventory control, fares & ticketing, and departure control functions. Maldivian has chosen IBS’ solution for its cost-effectiveness, optimum fit, short implementation time and flexible features that include Web Distribution, GDS, and